| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Galera Therapeutics, Inc. (GRTX) has 1 insider with recent SEC Form 4 filings, including 8 buys and 8 sells. GRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 195.0K | $16.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 21, 2020 | Holmlund Jon T | Chief Medical Officer | Sale+OE | 2,143 | $12.00 | $25,716.00 | -100% | |
| May 12, 2020 | Holmlund Jon T | Chief Medical Officer | Sale+OE | 5,958 | $12.00 | $71,496.00 | -100% | |
| May 7, 2020 | Holmlund Jon T | Chief Medical Officer | Sale+OE | 6,612 | $12.07 | $79,835.68 | -100% | |
| Dec 13, 2019 | Alleva Lawrence M | Director | Buy | 4,000 | $9.78 | $39,138.80 | New | |
| Nov 12, 2019 | Clarus IV-A, L.P. | 10% Owner | Buy | 250,000 | $12.00 | $3,000,000.00 | +17.5% | |
| Nov 12, 2019 | Novo Holdings A/s58 | 10% Owner, See Remarks | Buy | 500,000 | $12.00 | $6,000,000.00 | +17.2% | |
| Nov 12, 2019 | New Enterprise Associates 14, L.P. | 10% Owner | Buy | 416,666 | $12.00 | $4,999,992.00 | +10.6% | |
| Nov 12, 2019 | Sofinnova Venture Partners Ix, L.P. | 10% Owner | Buy | 750,000 | $12.00 | $9,000,000.00 | +32.1% |